Yan Sun

9.5k citations
91 papers · 2.5k indexed · 1 hit paper · h-index 25
Topics
Lung Cancer Treatments and Mutations (8 papers)CAR-T cell therapy research (7 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers)

In The Last Decade

Yan Sun

88 papers receiving 2.5k citations

Hit Papers

Randomized, Multicenter, Open-Label Study of Oxaliplatin ...20132026201720212013100200300

Peers

Yan Sun
Comparison fields: 5 of 125
  • Molecular Biology 921
  • Oncology 658
  • Pulmonary and Respiratory Medicine 597
  • Cancer Research 365
  • Pharmacology 353
Replace Pamela B. Conley with:
Pamela B. Conley United States
Chunfa Jie United States
Ming Lu China
James P. O’Brien United States
J M Wood Switzerland
Qi Cao China
Wei Xu China
Robert G. Kilbourn United States
Chieko Mineo United States
Yan Sun relative to Pamela B. Conley United States Pamela B. Conley's profile →
Citations per field
00.5×2.7×
Pamela B. Conley · 1×
Citations per year

Countries citing papers authored by Yan Sun

Since Specialization
Citations

This map shows the geographic impact of Yan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Sun more than expected).

Fields of papers citing papers by Yan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Sun. The network helps show where Yan Sun may publish in the future.

Co-authorship network of co-authors of Yan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Sun. A scholar is included among the top collaborators of Yan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Sun. Yan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 0
4 1
5 3
6 8
7 4
8 10
9 14
10 9
11 9
12 5
13 9
14 5
15 5
16 9
17 47
18 150
19 98
20 9

About Yan Sun

Yan Sun is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 91 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), CAR-T cell therapy research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). The work is most often cited by research in Hepatology (336 citations), Cancer Research (365 citations) and Oncology (658 citations). Yan Sun has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Andrew J. Bennett, David P. Weliky, David A. Kendall, Shukui Qin, Yuxian Bai, Jia Fan, Jee Hyun Lee, Tsai‐Shen Yang, Sumitra Thongprasert and Yee Chao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026